Bank of America initiated coverage on shares of National Health Investors (NYSE:NHI - Get Free Report) in a research note issued on Tuesday, Briefing.com reports. The brokerage set a "buy" rating and a $92.00 price target on the real estate investment trust's stock. Bank of America's price target points to a potential upside of 8.50% from the company's previous close.
NHI has been the subject of several other reports. StockNews.com raised shares of National Health Investors from a "hold" rating to a "buy" rating in a research report on Thursday, August 8th. Wells Fargo & Company raised their price objective on shares of National Health Investors from $63.00 to $69.00 and gave the stock an "overweight" rating in a report on Thursday, May 30th. Finally, Truist Financial upped their target price on National Health Investors from $65.00 to $78.00 and gave the stock a "hold" rating in a report on Friday, August 30th. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $68.75.
Read Our Latest Report on NHI
NYSE NHI opened at $84.79 on Tuesday. The business's 50-day moving average is $77.94 and its 200 day moving average is $69.08. The stock has a market capitalization of $3.68 billion, a PE ratio of 27.80, a PEG ratio of 8.67 and a beta of 1.04. The company has a debt-to-equity ratio of 0.91, a current ratio of 10.27 and a quick ratio of 10.27. National Health Investors has a 1 year low of $48.51 and a 1 year high of $86.13.
National Health Investors (NYSE:NHI - Get Free Report) last posted its earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.10 by ($0.29). National Health Investors had a net margin of 39.11% and a return on equity of 10.11%. The business had revenue of $84.97 million for the quarter, compared to analysts' expectations of $64.95 million. During the same period last year, the firm posted $1.06 earnings per share. National Health Investors's quarterly revenue was up 9.1% on a year-over-year basis. Sell-side analysts forecast that National Health Investors will post 4.55 earnings per share for the current year.
Large investors have recently bought and sold shares of the business. Strategic Financial Concepts LLC purchased a new stake in shares of National Health Investors during the 2nd quarter valued at about $28,000. Compass Wealth Management LLC bought a new stake in National Health Investors in the 1st quarter worth approximately $30,000. International Assets Investment Management LLC purchased a new stake in National Health Investors during the 2nd quarter valued at $36,000. Blue Trust Inc. raised its stake in National Health Investors by 2,651.9% during the 2nd quarter. Blue Trust Inc. now owns 743 shares of the real estate investment trust's stock valued at $47,000 after buying an additional 716 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its holdings in shares of National Health Investors by 66.2% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 2,594 shares of the real estate investment trust's stock valued at $163,000 after buying an additional 1,033 shares during the period. 62.51% of the stock is currently owned by institutional investors.
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.